ArticleCureus2025
Comparative Analysis of the One- Versus Two-Bag Method for the Treatment of Diabetic Ketoacidosis in Adults.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Diabetic ketoacidosis (DKA) is a significant complication of diabetes mellitus, and prompt standardized management protocols are critical. In addition to insulin therapy, traditional intravenous (IV) fluid management has been provided in a one-bag method with either normal saline, lactated Ringer's, or balanced crystalloids. Several researchers have explored the use of a two-bag method of fluid administration, which includes one IV fluid bag with either normal saline, lactated Ringer's, or balanced crystalloids in addition to an IV fluid with dextrose. The findings demonstrated that patients with DKA who received the two-bag method had greater clinical benefits than patients who received the one-bag IV fluid method. This study compared the effectiveness and safety of a one-bag IV fluid administration versus a two-bag method in patients with DKA. Methods This retrospective study evaluated DKA patients treated with a one-bag IV fluid method at our institution compared to previously published data using one-bag and two-bag methods. Effectiveness was measured as the time to anion gap closure, pH ≥7.3, and bicarbonate ≥18 mEq/L. Safety was evaluated by occurrences of hypokalemia and hypoglycemia. Data were reported as study (S1) vs control (C1 or C2). IBM SPSS Statistics for Windows, Version 28 (Released 2021; IBM Corp., Armonk, New York, United States). Results Of the 598 S1 patients evaluated, 238 patients were included for analysis with a mean age of 45.4±18.9 years and Acute Physiology and Chronic Health Evaluation II (APACHE-II) of 15.1±5.8. Time to pH≥7.3 was shorter in C1 (p<0.01) and C2 (p<0.01) groups compared to S1. The mean duration of insulin infusion was shorter in both C1 (36.1±31.8 S1 vs 21.8±25.8 C1, hr; p<0.01) and C2 (36.1±31.8 S1 vs 14.1±10.7 C2, hr; p<0.01). Hospital length of stay was shorter in C1 (3.4±4.5 C1 vs 5.9±5.3 S1, days; p<0.01) and C2 (3.1±4.1 C2 vs 5.9±5.3 S1 days; p<0.01). Hypoglycemia was observed more in the S1 group (30%) compared to the C1 (10%) and C2 (3%) groups. Conclusions Compared to the control groups of adult patients, the S1 group was associated with increased duration of insulin infusion, risk of hypoglycemia, and prolonged hospital stay. Institution-specific DKA management protocols should be evaluated to ensure optimal treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.